In this issue:
Long-term benefits of tebentafusp
Safety and efficacy of nivolumab
LMM patients and sentinel lymph node biopsy positivity risk
OS benefits of CLND
Significance of incipient ulceration
Histologic margin status predicting disease progression
Validity of MIA nomogram
Characterising melanoma patients diagnosed during COVID-19
Global burden of melanoma
Please login below to download this issue (PDF)